Global Pimozide Market Report, History and Forecast 2013-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application - Market Overview

The Pimozide Market Research report clarifies the past experience and trends, on the basis of these past experiences, it offers the future prediction considering other factors influencing the growth rate. This worldwide report offers the detailed analysis of the important factors such as market dynamics (DROT), PEST, and PORTER which assists the growth of the Pimozide Industry. These past experience and factors assist to build the strategy and future planning of Pimozide Market and hold a place in the competitive world.

The Pimozide industry Market report offers the competitive scenario in the Pimozide industry based on the type of product, applications, and the companies that are present in the Pimozide market, and covers the company profiles, their development policies, lined up products and recent launched along with the SWOT analysis of companies.

To get a complete report sample from this link: http://www.qyresearchglobal.com/goods-1718878.html

This report studies the Pimozide market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.

The global average price of Pimozide is in the increasing trend, from 1.13 USD/Unit in 2013 to 1.19 USD/Unit in 2017. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of Pimozide includes 1Mg, 2Mg, 4Mg, and the proportion of 2Mg in 2017 is about 53%.
Pimozide is widely used in hospitals, drugstores and other places. The most proportion of Pimozide is used for hospitals in 2017 is 54%.

The global Pimozide market was 12 million US$ in 2017 and is expected to 11 million US$ by the end of 2025, growing at a CAGR of -0.9% between 2018 and 2025.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pimozide in these regions, from 2013 to 2025, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
    Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
    South America (Brazil etc.)
    Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
    Teva
    Par Pharmaceutical
    Johnson & Johnson
    Eumedica
    Pharmascience
    Domina Pharmaceuticals
    Aa Pharma
By the product type, the market is primarily split into
    1Mg
    2Mg
    4Mg
By the end users/application, this report covers the following segments
    Hospitals
    Drugstores
    Others

The study objectives of this report are:

To study and analyze the global Pimozide market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.

To understand the structure of Pimozide market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Pimozide manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Pimozide with respect to individual growth trends, future prospects, and their contribution to the total market.

To project the value and volume of Pimozide submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Contact Details:

Company Name: QYResearch CO.,LIMITED | focus on Market Survey and Research

Tina| Sales Managers

Tel: 0086-20-22093278(CN)

Email: sales@qyresearchglobal.com or tinaning@qyresearch.com

Web: http://www.qyresearchglobal.com/